Membrane localization, Caveolin-3 association and rapid actions of vitamin D receptor in cardiac myocytes

The active form of vitamin D, 1alpha, 25-dihydroxyvitamin D 3 (1,25(OH) 2D 3), mediates both genomic and rapid non-genomic actions in heart cells. We have previously shown that the vitamin D receptor (VDR) is located in the t-tubular structure of cardiomyocytes. Here we show that VDR specifically in...

Full description

Saved in:
Bibliographic Details
Published inSteroids Vol. 75; no. 8; pp. 555 - 559
Main Authors Zhao, Guisheng, Simpson, Robert U.
Format Journal Article Conference Proceeding
LanguageEnglish
Published Kidlington Elsevier Inc 01.08.2010
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The active form of vitamin D, 1alpha, 25-dihydroxyvitamin D 3 (1,25(OH) 2D 3), mediates both genomic and rapid non-genomic actions in heart cells. We have previously shown that the vitamin D receptor (VDR) is located in the t-tubular structure of cardiomyocytes. Here we show that VDR specifically interacts with Caveolin-3 in the t-tubules and sarcolemma of adult rat cardiac myocytes. Co-immunoprecipitation studies using VDR antibodies revealed that Caveolin-3 specifically co-precipitates with the VDR and similarly the VDR is co-precipitated with Caveolin-3 antibody. Confocal immuno-fluorescence microscopy analysis also showed co-localization of VDR and Caveolin-3 in t-tubules and sarcolemma. The non-genomic effects of the functional VDR were studied in electrically stimulated myocytes isolated from adult rat hearts. Sarcomere shortening and re-lengthening were measured in 1,25(OH) 2D 3 treated cardiac myocytes. A 1 nM treatment decreased peak shortening within minutes, suggesting a rapid effect through the membrane-bound VDR. This novel finding of the interaction between VDR and Caveolin-3 is fundamentally important in understanding 1,25(OH) 2D 3 signal transduction in heart cells and provides further evidence that VDR plays a role in regulation of heart structure and function.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0039-128X
1878-5867
DOI:10.1016/j.steroids.2009.12.001